Literature DB >> 26148956

Trends in Hospitalization for Pediatric Pulmonary Hypertension.

Bryan G Maxwell1, Melanie K Nies2, Chinwe C Ajuba-Iwuji3, John D Coulson2, Lewis H Romer4.   

Abstract

BACKGROUND AND OBJECTIVES: Pulmonary hypertension (PH) has been associated with substantial morbidity and mortality in children, but existing analyses of inpatient care are limited to small single-institution series or focused registries representative of selected patient subgroups. We examined US national data on pediatric PH hospitalizations to determine trends in volume, demographics, procedures performed during admission, and resource utilization.
METHODS: Retrospective cohort study using a national administrative database of pediatric hospital discharges: the Kids' Inpatient Database.
RESULTS: Children with PH accounted for 0.13% of the 43 million pediatric hospitalizations in the United States between 1997 and 2012, and discharges demonstrated an increasing trend over the study period (P < .0001). Cumulative, inflation-adjusted national hospital charges for PH hospitalizations rose (P = .0003) from $926 million in 1997 to $3.12 billion in 2012. Patients with PH without associated congenital heart disease (CHD) comprised an increasing and majority (56.4%) proportion over the study period (P < .0001), children without associated CHD admitted at urban teaching hospitals comprised the fastest-growing subgroup. In-hospital, all-cause mortality was high (5.9%) in children with PH, but demonstrated a decreasing trend (P < .0001).
CONCLUSIONS: Morbidity and mortality of pediatric PH continue to represent substantial and growing health care burdens. Shifts in case mix toward PH not associated with CHD, toward noncardiac procedures, and toward care in urban teaching hospitals will increase pressure to manage resource utilization in this small but growing patient group and to improve expertise and define excellence in PH care across a wide range of clinical settings.
Copyright © 2015 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2015        PMID: 26148956     DOI: 10.1542/peds.2014-3834

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  18 in total

1.  Hospitalizations of Children With Pulmonary Hypertension: Implications for Improving Care.

Authors:  Steven H Abman; D Dunbar Ivy
Journal:  Pediatrics       Date:  2015-07-06       Impact factor: 7.124

2.  Trends in Bronchiolitis Hospitalizations in the United States: 2000-2016.

Authors:  Michimasa Fujiogi; Tadahiro Goto; Hideo Yasunaga; Jun Fujishiro; Jonathan M Mansbach; Carlos A Camargo; Kohei Hasegawa
Journal:  Pediatrics       Date:  2019-11-07       Impact factor: 7.124

Review 3.  Treatment of Pediatric Pulmonary Hypertension.

Authors:  Manish Aggarwal; R Mark Grady
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-02-20

Review 4.  Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies.

Authors:  Helen Christou; Raouf A Khalil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-02-25       Impact factor: 4.733

Review 5.  Pulmonary Hypertension in Children.

Authors:  Dunbar Ivy
Journal:  Cardiol Clin       Date:  2016-08       Impact factor: 2.213

6.  Executive Summary of the American Heart Association and American Thoracic Society Joint Guidelines for Pediatric Pulmonary Hypertension.

Authors:  Steven H Abman; D Dunbar Ivy; Stephen L Archer; Kevin Wilson
Journal:  Am J Respir Crit Care Med       Date:  2016-10-01       Impact factor: 21.405

Review 7.  Persistent Challenges in Pediatric Pulmonary Hypertension.

Authors:  Rachel K Hopper; Steven H Abman; D Dunbar Ivy
Journal:  Chest       Date:  2016-01-22       Impact factor: 9.410

8.  Change in Pediatric Functional Classification During Treatment and Morbidity and Mortality in Children with Pulmonary Hypertension.

Authors:  Emily Morell Balkin; Emma D Olson; Laura Robertson; Ian Adatia; Jeffrey R Fineman; Roberta L Keller
Journal:  Pediatr Cardiol       Date:  2016-02-03       Impact factor: 1.655

Review 9.  Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant.

Authors:  Lidys Rivera; Roopa Siddaiah; Christiana Oji-Mmuo; Gabriela R Silveyra; Patricia Silveyra
Journal:  Front Pediatr       Date:  2016-03-31       Impact factor: 3.418

10.  Perioperative events in children with pulmonary hypertension undergoing non-cardiac procedures.

Authors:  Meghan L Bernier; Ariel I Jacob; Joseph M Collaco; Sharon A McGrath-Morrow; Lewis H Romer; Chinwe C Unegbu
Journal:  Pulm Circ       Date:  2017-10-03       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.